MRNA logo

MRNA Moderna, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$195.00
-4.33 (-2.17%)

Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning…

Market Cap: $78.90Bwww.modernatx.com

Price

$195.00+22.77%
$135.61$180.07$224.54$269.00
Aug 25Nov 20

Social Signal Score

54
5d
58
8 mentions
-5.7%
30d
51
101 mentions
-2.5%
60d
53
230 mentions
+7.1%
90d
54
348 mentions
+40.4%
news: 165 · marketaux: 15 · 4chan: 77 · rss: 87 · podcast: 4

Analyst Ratings

29 analysts
Holdconsensus
Strong Buy 0Buy 7Hold 16Sell 6Strong Sell 0
Avg price target$143.67-26.3%
Low $25Median $132.5High $305
Current Consensus

52-week range

$22.36$269.00
Last close
$195.00
Off 52w high
-27.5%
200-day average
$100.42
vs 200-day
+94.2%

Compare with other stocks off their highs

Revenue

$1.31B+3575.40%
$8.39M$2.32B$4.64B$6.95B
Mar 2017Sep 2026

Analyst Estimates

FY2025
$-7.84
$-8.40–$-7.28
15 analysts
FY2026
$-7.41
$-9.48–$-2.92
16 analysts
FY2027
$-4.33
$-6.96–$-2.49
17 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Stéphane Bancel
Sector
Healthcare
Industry
Biotechnology
Employees
4,700
Beta
0.90
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
7.68
www.modernatx.com